Dr. John's Candies, LLC – Trademark Portfolio

Entity Type: 16

Dr. John's Candies, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DR. JOHN'S. The owner is based in Grand Rapids, MI.

2242 Cardiff Ct NE

Grand Rapids, MI 49505

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Dr. John's Candies, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

30
Staple Foods (3 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Dr. John's Candies, LLC have?

Dr. John's Candies, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.

What trademark classes does Dr. John's Candies, LLC file in?

Dr. John's Candies, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 5 (Pharmaceuticals). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.

What are Dr. John's Candies, LLC's most well-known trademarks?

Dr. John's Candies, LLC's registered trademark portfolio includes well-known marks such as DR. JOHN'S. These are among 1 currently registered trademark in the portfolio.

What is Dr. John's Candies, LLC's trademark registration success rate?

Dr. John's Candies, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.